News | November 10, 2021
Strides Pharma Science incurs Rs 162.55 cr. loss in Q2FY22
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.
Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
